The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery

Purpose. To evaluate the safety and efficacy of intracameral vancomycin during cataract surgery using a standardized dosage and delivery technique. Methods. The charts of 20,719 consecutive eyes that underwent phacoemulsification with intraocular lens implantation in a single ambulatory surgery cen...

Full description

Saved in:
Bibliographic Details
Main Authors: Sloan W. Rush, Duy Vu, Ryan B. Rush
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/813697
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683841678049280
author Sloan W. Rush
Duy Vu
Ryan B. Rush
author_facet Sloan W. Rush
Duy Vu
Ryan B. Rush
author_sort Sloan W. Rush
collection DOAJ
description Purpose. To evaluate the safety and efficacy of intracameral vancomycin during cataract surgery using a standardized dosage and delivery technique. Methods. The charts of 20,719 consecutive eyes that underwent phacoemulsification with intraocular lens implantation in a single ambulatory surgery center were retrospectively reviewed over a 5-year period. Results. The first 11,333 consecutive cases did not receive intracameral vancomycin, whereas the next 9,386 consecutive cases all received intracameral vancomycin. There were no significant differences in the baseline characteristics between the cohort of subjects who received intracameral vancomycin and the cohort of subjects that did not. There were a total of 11 subjects (0.97 cases per 1,000) that developed postoperative endophthalmitis in the group that did not receive intracameral vancomycin, whereas there were no cases of postoperative endophthalmitis in the group that received intracameral vancomycin (p = 0.0015). The overall rate of intraoperative and postoperative complications and the final postoperative visual acuities were similar among cohorts. There were no cases of toxic anterior segment syndrome occurring in either group during the study period. Conclusions. Routine administration of intracameral vancomycin during cataract surgery significantly decreased the incidence of postoperative endophthalmitis and was not associated with an increased incidence of postoperative adverse events.
format Article
id doaj-art-d6ae658d122c4c8f9b9c90f27bc1f474
institution DOAJ
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-d6ae658d122c4c8f9b9c90f27bc1f4742025-08-20T03:23:41ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/813697813697The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract SurgerySloan W. Rush0Duy Vu1Ryan B. Rush2Panhandle Eye Group, 7400 Fleming Avenue, Amarillo, TX 79106, USATexas Tech University Health Sciences Center, 1400 S. Coulter, Amarillo, TX 79106, USAPanhandle Eye Group, 7400 Fleming Avenue, Amarillo, TX 79106, USAPurpose. To evaluate the safety and efficacy of intracameral vancomycin during cataract surgery using a standardized dosage and delivery technique. Methods. The charts of 20,719 consecutive eyes that underwent phacoemulsification with intraocular lens implantation in a single ambulatory surgery center were retrospectively reviewed over a 5-year period. Results. The first 11,333 consecutive cases did not receive intracameral vancomycin, whereas the next 9,386 consecutive cases all received intracameral vancomycin. There were no significant differences in the baseline characteristics between the cohort of subjects who received intracameral vancomycin and the cohort of subjects that did not. There were a total of 11 subjects (0.97 cases per 1,000) that developed postoperative endophthalmitis in the group that did not receive intracameral vancomycin, whereas there were no cases of postoperative endophthalmitis in the group that received intracameral vancomycin (p = 0.0015). The overall rate of intraoperative and postoperative complications and the final postoperative visual acuities were similar among cohorts. There were no cases of toxic anterior segment syndrome occurring in either group during the study period. Conclusions. Routine administration of intracameral vancomycin during cataract surgery significantly decreased the incidence of postoperative endophthalmitis and was not associated with an increased incidence of postoperative adverse events.http://dx.doi.org/10.1155/2015/813697
spellingShingle Sloan W. Rush
Duy Vu
Ryan B. Rush
The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
Journal of Ophthalmology
title The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
title_full The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
title_fullStr The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
title_full_unstemmed The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
title_short The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery
title_sort safety and efficacy of routine administration of intracameral vancomycin during cataract surgery
url http://dx.doi.org/10.1155/2015/813697
work_keys_str_mv AT sloanwrush thesafetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery
AT duyvu thesafetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery
AT ryanbrush thesafetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery
AT sloanwrush safetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery
AT duyvu safetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery
AT ryanbrush safetyandefficacyofroutineadministrationofintracameralvancomycinduringcataractsurgery